Headline

Commercial & BD Leader | Pharma | Growth and P&L Managment | Strategy & Operations | Ex-Cipla

About

I work in pharmaceutical commercial leadership — business development, revenue management, and key account growth — with a supply chain and operations background that shapes how I approach commercial planning. Over the past 10+ years, I've worked across India, Europe, Emerging Markets, and East Africa, in roles spanning Cipla and IMCD Group (part of the €5+ Bn IMCD Group). At IMCD, I currently manage ₹800+ Cr in principal relationships, covering B2B contract negotiation and share-gain initiatives that have grown category penetration 10% YoY. Before this, at Cipla, I led Revenue Management for a $500 Mn EMEU Rx portfolio, worked in the Global COO's office on cross-regional growth initiatives, and spent two years as Head of Supply Chain Management for Cipla's East Africa business. That mix means my commercial planning tends to account for delivery constraints early, rather than after the fact. A few specifics from along the way: • ₹800+ Cr in B2B principal relationships managed at IMCD Group • 8 consecutive quarters on-target across a $500 Mn Rx portfolio at Cipla EMEU • Originated a $60 Mn in-licensing and hospital-channel BD opportunity • 90% launch success rate across a $10 Mn revenue programme in 4 countries • Contributed to 28% revenue growth over 2 years across US, Europe & EM Rx portfolios I'm looking to build further depth in pharma commercial leadership — business development, commercial excellence, and key account roles across generic and innovator pharma. Happy to connect with others working in pharma commercial and BD IIT Bombay | Ashoka University Let's connect at (+91) 9619435762 or rohansablay415@gmail.com.

Location

Mumbai

AI stack

claude

grok

meta

openai

ChatGPT

Work experience

Lead - BD & Commercial Operations at Signet Excipients Pvt. Ltd., Mar 2025 - Present · 1 yr 7 mos, Mumbai, Portfolio Managment: 8 principals (XX Crs) managed Business Development: 20+ excipients evaluated; 3 commercialised Adjacencies: Development of Medical devices segment M&A: Evaluated RLD sourcing company for backward integration & development access

Growth Management - LATAM at Pocket FM, Sep 2024 - Feb 2025 · 6 mos, Mexico City, Mexico

Associate Director | Commercial Operations | Cipla EMEU at Cipla, Jul 2022 - Sep 2024 · 2 yrs 3 mos, Mumbai, - Revenue Management & Business Operations for EMEU (~500 Mn $ revenue) - Setup and optimised the order to deliver process to driver 8Qs (2 years) revenue inline with management expectation - Aided problem solving across cross function teams including manufacturing, supply chain and 5 regional business segments regularly to identify risk and opportunities

Senior Manager | Head of Supply Chain Management| Cipla QCIL at Quality Chemical Industries Limited, Aug 2020 - Jun 2022 · 1 yr 11 mos, Kampala, Secondment Assignment to Cipla QCIL from Cipla - Drove turnaround initiatives as the youngest HOD and member of a 9-member Executive Council - Built and led a 10-member team to restructure the SCM function and define the 0-1 journey. - Delivered $4M EBITDA savings to turnaround the EBITDA margin % on a $75M revenue base - Awarded Exception Performance Rating

Senior Manager | Special Projects | Global CTO's Office at Cipla, 2020 - 2020 · Less than a year, - Aided commercial and supply-chain problem solving for the South Africa and Sub-Saharan Africa businesses during COVID-19, mitigating supply disruptions and supporting revenue delivery across portfolios

Manager | Global COO's Office at Cipla, 2018 - 2020 · 2 yrs, - Lead the Office of Global COO's (R Ananthanarayanan, PhD) to spearhead special projects, track key performance metrics across businesses and drive governance. - Aided operational excellence initiatives including manufacturing capacity de-bottlenecking, OEE improvement, and launch-readiness programs, enhancing supply reliability across multiple therapeutic portfolios. - Aided commercial problem-solving and execution by supporting revenue delivery commitments across portfolios representing ~40% of Cipla's $2.5Bn topline, balancing customer service, growth, and supply-chain constraints.

Manager| Commercial Launch Management | EU & Russia CIS at Cipla, 2018 - 2018 · Less than a year, - Delivered 90% Day-1 launch success for 10 new products across multiple therapies through coordinated supply chain, regulatory, and commercial execution.

Education

Integrated Dual Degree (B.Tech + M.Tech), Civil Engineering | Specialization: Structural Engineering, Indian Institute of Technology, Bombay

Post Graduate Diploma (YIF), Liberal Studies and Leadership, Ashoka University